000 01275 a2200349 4500
005 20250515201854.0
264 0 _c20100902
008 201009s 0 0 jpn d
022 _a0009-918X
024 7 _a10.5692/clinicalneurol.49.747
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSobue, Gen
245 0 0 _a[Molecular-targeted therapy for neurodegenerative diseases].
_h[electronic resource]
260 _bRinsho shinkeigaku = Clinical neurology
_cNov 2009
300 _a747-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aBulbo-Spinal Atrophy, X-Linked
_xetiology
650 0 4 _aClinical Trials as Topic
650 0 4 _aExons
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeuprolide
_xtherapeutic use
650 0 4 _aMice
650 0 4 _aNeurodegenerative Diseases
_xetiology
650 0 4 _aReceptors, Androgen
_xgenetics
650 0 4 _aTestosterone
_xphysiology
650 0 4 _aTranslational Research, Biomedical
650 0 4 _aTrinucleotide Repeat Expansion
773 0 _tRinsho shinkeigaku = Clinical neurology
_gvol. 49
_gno. 11
_gp. 747-9
856 4 0 _uhttps://doi.org/10.5692/clinicalneurol.49.747
_zAvailable from publisher's website
999 _c19410653
_d19410653